Immunogen reported $15.38M in Sales Revenues for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbvie ABBV:US USD 14.81B 229M
Agios Pharmaceuticals AGIO:US USD 3.52M 2.07M
Amgen AMGN:US USD 6.84B 187M
Astellas Pharma 4503:JP JPY 380.39B 1.4B
AstraZeneca AZN:LN USD 10.98B 211M
Bluebird Bio BLUE:US USD 71K 1.45M
Bristol Myers Squibb BMY:US USD 11.41B 188M
Eli Lilly And LLY:US USD 7.3B 360.2M
Emergent Biosolutions EBS:US USD 240M 2.7M
Exelixis EXEL:US USD 411.74M 7.69M
Halozyme Therapeutics HALO:US USD 208.98M 56.61M
Heron Therapeutics HRTX:US USD 26.56M 1.07M
Immunogen IMGN:US USD 15.38M 1.21M
Intrexon XON:US USD 16.72M 13.81M
Karyopharm Therapeutics KPTI:US USD 36.14M 3.53M
Macrogenics MGNX:US USD 41.73M 15.73M
Nektar Therapeutics NKTR:US USD 23.62M 2.04M
Novartis NVS:US USD 13B 159M
Pfizer PFE:US USD 24.29B 1.65B
Regeneron Pharmaceuticals REGN:US USD 3.41B 478.2M
Roche Holding ROG:VX CHF 32.3B 207M
Seattle Genetics SGEN:US USD 510.3M 12.8M